期刊名称：RECENT PATENTS ON NANOTECHNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Recent Patents on Nanotechnology publishes review and research articles, and guest edited thematic issues on recent patents in the field of nanotechnology. A selection of important and recent patents on nanotechnology is also included in the journal. The journal is essential reading for all researchers involved in nanotechnology.
Indexed in:
SciSearch®, Journal Citation Reports/Science Edition, Materials Science Citation Index®, Chemical Abstracts, MEDLINE/PubMed, Scopus, Compendex, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory.
Instructions to Authors
Manuscripts may be divided into the following sections:
1. Covering Letter: It is mandatory to submit a signed covering letter along with the manuscript, by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article should not contain any material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors should acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copy right agreement. DOWNLOAD COVERING LETTER
2. Title: The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations. The title must be written in title case except for articles, conjunctions and prepositions.
Title, running title, byline, correspondent footnote and keywords should be written as presented in original manuscripts.
3. Short Running Title: Authors must provide a short ‘running title’ of their manuscript.
4. Authors’ Names and Affiliations: The names of the authors should be provided according to previous citations or as the authors would want them to be published along with the institutional affiliations and current address, telephone, cell & fax numbers and the email address must be provided, with an asterisk in front of the name of the principal author. The corresponding author should also be designated and the full address, telephone, cell & fax numbers and the email address must be stated to receive correspondence and galley proofs.
5. Abstract: The abstract summarizing the essential features of the review or research article should not exceed 200 words and must include information regarding patents.
6. Keywords: Authors must provide 15 to 20 keywords in alphabetical order.
7. Text Organization: The main text should begin on a separate page and should be divided into title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed, which should be followed by the Acknowledgement (if any) and Reference sections. The Review Article should mention any previous important, recent and old reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments along with relevant patents. The authors should avoid presenting material which has already been published in a previous review. The authors are advised to present and discuss their observations in brief. The manuscript style must be uniform throughout the text and 10pt Times New Roman fonts should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al., in vitro, in vivo, in situ, etc.
For Research Articles, the manuscript should begin with the title page and abstract followed by the main text, which must be structured into separate sections as Introduction, Material and Methods, Results, Discussion, Conclusion, Current & Future Developments, Conflict of Interest, Acknowledgements and References. The patent registration number and patent authority of the author's intellectual property must be cited in the article.
Ethical Approval of Studies and Informed Consent: For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee and should be documented in your paper. For investigations undertaken on human subjects, state in the Methods section the manner in which the informed consent was obtained from the study participants (i.e., oral or written), where there is an unavoidable risk of breach of privacy- e.g., in a clinical photograph or in case details- the patient’s written consent or that of the next of kin, to publication must be obtained. We will ask you to send a signed consent form before publication. Consent must be obtained for all Case Reports and Clinical Pictures.
Patent Review Coverage: Authors should review the most recent and important patents based on the topic covered. Coverage of novel bioactive compounds, analogs & targets, techniques and drug design in all areas of nanotechnology should be emphasized, including the significance of reported patents.
Current & Future Developments: The review article should conclude with a short section called “Current & Future Developments”. The author(s) will give their opinion on the current and future important developments on the topic discussed in their article.
Symbols and Units: Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of a manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during the conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These guidelines provide a set of recommendations comprising a list of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the various parameters. All kinds of measurements should be reported only in International System of Units (SI). SI units should always be written in Roman and separated from the numerical value by a space (whatever the language).
The µ in µg or µm should be in Roman. The symbol for litre is L and that for minute is min. For temperature, please use only one of °C, °F or K in the entire manuscript. As the Angström (1Å = 10-10 m) is not an SI unit, it should be replaced by the nanometre (1nm = 10-9 m) or by the picometer (1pm = 10-12 m): 1Å = 0.1nm = 100 pm. Multiple units should be written with negative superscripts (for example, 25mgµL-1 µs-1). The list of notations should appear just before the first paragraph of full text.
A list of symbols and units should be provided if used extensively throughout the text.
8. List of Abbreviations (if any): If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.
9. Acknowledgements (if any): Financial contributions to the work being reported should be clearly acknowledged. Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgement section.
This journal complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals www.icmje.org and the FDA's Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices www.fda.gov/oc/op/goodreprint.html
10. Conflict of Interest (if any): Any potential conflict of interest should be clearly acknowledged. No patents should be cited by authors that are in various stages of legal litigation.
11. References: References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. All references must be complete and accurate. Online citations should include the date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less, If the number of authors exceeds 6 then list the first 3 authors and then use et al. The reference numbers must be finalized and the bibliography must be fully formatted before submission.
References should be listed in the following Vancouver Style:
Journal:
[1] Boehm M, Nabel EG. Angiotensin-converting enzyme 2 - A new cardiac regulator. N Engl J Med 2002; 347: 1795-7.
Book:
[2] Crabtree RH. The organometallic chemistry of the transition metals. 3rd ed. New York: Wiley & Sons 2001.
Book Chapter:
[3] Yeh DC, Rocco T. In: David EG, Armen HT, Ehrin JA, April WA, Eds. Integrative cardiovascular pharmacology. Philadelphia: Lippincott Williams & Wilkins 2005: pp. 375-83.
Conference Proceedings:
[4] Jakeman DL, Withers SGE. Carbohydrate bioengineering: interdisciplinary approaches. Proceedings of the 4th Carbohydrate Bioengineering Meeting. Stockholm, Sweden, June 10-13, 2001.
Meeting Abstract:
[5] Hoffman BJ. Metabolism: amino acid transporters as targets for therapeutic intervention. American Chemical Society - 228th National Meeting. Philadelphia, USA 2004.
Website:
[6] National Library of Medicine. Specialized information services: Toxicology and environmental health. Available at: http://sis.nlm.nih.gov/Tox/ToxMain.html (Accessed on: May 23, 2009).
Thesis:
[7] Mackel H. Capturing the spectra of silicon solar cells. PhD Thesis, The Australian National University, Canberra, Australia, December 2004.
Patent: As a service, the Publishers can provide each author a certain number of relevant patents to assist them in writing their article. All patent application references will be provided by the author and will be published as it is.
Patent Reference Style: All inventors’ names of the cited patents must be stated with the title, publication number and the year of publication e.g. Chesnut JD, Carrino J, Leong L, Madden K, Gleeson MAG, Fan J, Brasch MA, Cheo D, Hartley JL, Byrd DRN, Temple GF. Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites. US7198924, 2007.
Citation of the patents will be according to the international convention as follows:
WO Patents: 1978-2003
[1] Miranda J, Sablotsky S. Solubility parameter based drug delivery system and method for altering drug saturation concentration. WO9300058, 1993.
[2] Huang D, Qi DF. Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents. WO03024459, 2003.
WO Patents: 2004 onwards
[1] Balzarini J, Liekens S. Anti-cancer combination therapy. WO2009138507, 2009.
US Patent Applications: 2001 onwards
[1] Strelchenok O. New compounds for the treatment of cancer. US20010018425, 2001.
[2] Landau BR, Landau S. Treatment of cancer with 2-Deoxygalactose. US20090163442, 2009.
Issued/Granted US Patents:
[1] Sakamoto I, Takagi K. Anti-cancer device. US4536387, 1985.
[2] Baguley BC, Ching L-M, Philpott M. Cancer treatment by combination therapy. US7510830, 2009.
EP Patents:
[1] Rimm DL, Wardlaw SC, Levine RA, Fiedler P. Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hemotologic progenitor cells in whole blood. EP0919812A2, 1999.
[2] Miller TM, Jamison JM. Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone. EP2034835A2, 2009.
Some important points to remember:
• Superscripts in the in-text citations and reference section should be avoided.
• Abstracts, unpublished data and personal communications (which can only be included if prior permission has been obtained) should not be given in the reference section but they may be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted.
12. Tables (if any):
• Data tables should be submitted in Microsoft Word table format.
• Each table should include a title/caption being explanatory in itself with respect to the details discussed in the table. Detailed legends may then follow.
• Table number in bold font i.e. Table 1, should follow a title. The title should be in small case with the first letter in caps. A full stop should be placed at the end of the title.
• Tables should be embedded in the text exactly according to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct by ensuring that the borders of each cell are displayed as black lines.
• Tables should be numbered in Arabic numerals sequentially in order of their citation in the body of the text.
• If a reference is cited in both the table and text, please insert a lettered footnote in the table to refer to the numbered reference in the text.
• Tabular data provided as additional files can be submitted as an Excel spreadsheet.
13. Figures/Illustrations (if any): The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. The acceptance of a manuscript for publication is subject to the figures being up to the highest standards in terms of clarity and resolution. In case, the figures supplied are not up to the standards required, the authors will be given the option to either return the manuscripts within one week with appropriate drawings/figures or they may opt to have these professionally prepared through the paid professional service available from Bentham Publishing Services.
The authors should provide the illustrations as separate files, as well as embedded in the text file, numbered consecutively in the order of their appearance. Each figure should include a single illustration. Each figure should be closely cropped to minimize the amount of white space surrounding the illustration. If a figure consists of separate parts, it is important that a single composite illustration file be submitted, containing all parts of the figure.
Photographs should be provided with a scale bar if appropriate, as well as high-resolution component files.
Scaling/Resolution
For Line Art image type, which is generally an image based on lines and text and does not contain tonal or shaded areas, the preferred file format is TIFF or EPS, with color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.
For Halftone image type, which is generally a continuous tone photograph and contains no text, the preferred file format is TIFF, with color mode being or RGB or Grayscale, in a resolution of 300 dpi.
For Combination image type, which is generally an image containing halftone in addition to text or line art elements, the preferred file format is TIFF, with colour mode being or RGB or Grayscale, in a resolution of 500-900 dpi.
Formats
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for diagrams)
• PNG (preferred format for photos or images)
• Microsoft Word (version 5 and above; figures must be a single page)
• PowerPoint (figures must be a single page)
• TIFF
• JPEG (conversion should be done using the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted in GIF format.
If the large size of TIFF or EPS figures acts as an obstacle to online submission, authors may find that conversion to JPEG format before submission results in significantly reduced file size and upload time, while retaining acceptable quality. JPEG is a 'lossy' format. However, in order to maintain acceptable image quality, it is recommended that JPEG files are saved at high or maximum quality.
Files should not be compressed with tools such as Zipit or Stuffit prior to submission as these tools will in any case produce negligible file-size savings for JPEGs and TIFFs, which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet, presentation) document;
2. Supply files that are optimized for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the content.
Image Conversion Tools
There are many software packages, many of them freeware or shareware, capable of converting to and from different graphics formats, including PNG.
Good general tools for image conversion include GraphicConverter on the Macintosh, PaintShop Pro, for Windows, and ImageMagick, which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted to EPS, since this will result in a much larger file size than the equivalent JPEG, TIFF, PNG or BMP, with no increase in quality. EPS should only be used for images produced by vector-drawing applications such as Adobe Illustrator or CorelDraw. Most vector-drawing applications can be saved in, or exported as, EPS format. In case the images have been originally prepared in an Office application, such as Word or PowerPoint, then the original Office files should be directly uploaded to the site, instead of being converted to JPEG or another format that may be of low quality.
Color Figures/Illustrations
• The cost for the first published page of color figures is US$ 940; the second additional page will be for US$ 685 and each subsequent page for US$ 465.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures (if any):
Chemical structures MUST be prepared in ChemDraw (CDX file) and provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm, 0.2in)
Bold width 2.0 pt (0.071cm, 0.0278in)
Line width 0.6 pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times New Roman
Size 8 pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US letter
Scale 100%
14. Supportive/Supplementary Material (if any): We do encourage to append supportive material, for example a PowerPoint file containing a talk about the study, a PowerPoint file containing additional screenshots, a Word, RTF, or PDF document showing the original instrument(s) used, a video, or the original data (SAS/SPSS files, Excel files, Access Db files etc.) provided it is inevitable or endorsed by the journal's Editor.
Supportive/Supplementary material intended for publication must be numbered and referred to in the manuscript but should not be a part of the submitted paper. In-text citations as well as a section with the heading "Supportive/Supplementary Material" before the "References" section should be provided. Here, list all Supportive/Supplementary Material and include a brief caption line for each file describing its contents.
Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided only on our website. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet). Supportive/ Supplementary material must be provided in a single zipped file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced material should not be included unless you have obtained written permission from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of your article for publication.
For obtaining permission of reproducing any material published in an article by Bentham Science Publishers, please fill in the request FORM downloadable from the journal’s Web site and send to qasit@benthamscience.org for consideration.
Editorial Board
Editor-in-Chief:
Eduardo Ruiz- Hitzky
Department of New Architectures in Materials Chemistry
Materials Science Institute of Madrid
Madrid
Spain
Co-Editor in Chief:
Pilar Aranda
Department of New Architectures in Materials Chemistry
Materials Science Institute of Madrid
Madrid
Spain
Associate Editor:
Cengiz S. Ozkan
Department of Mechanical Engineering
University of California
Riverside, CA
USA
Regional Editor:
Oswaldo L. Alves
Laboratory of Solid State Chemistry (LQES)
UNICAMP
Campinas
Brazil
Editorial Advisory Board:
A. Agarwal (Florida International University, Miami, FL, USA)
V.S. Aigbodion (Ahmadu Bello University, Zaria, Nigeria)
P. Alexandridis (State University of New York, Buffalo, NY, USA)
P.E. Arce (TTU, Cookeville, TN, USA)
M.R. Baklanov (IMEC, Leuven, Belgium)
C. Balázsi (Research Institute For Technical Physics and Materials Science, Budapest, Hungary)
T.K.Bandyopadhyay (Indian Institute of Technology, Kharagpur, India)
M.I. Baraton (University of Limoges, Limoges, France)
A.R. Barron (Rice University, Houston, TX, USA)
S. Barth (Fraunhofer IME, Aachen, Germany)
R. Bawa (Bawa Biotech LLC, Ashburn, VA, USA and RPI, Troy, NY, USA)
S. Bhansali (University of South Florida, Tampa, FL, USA)
S.H. Bo (Qingdao University of Science and Technology, Qingdao, China)
J.H. Borrell (CBEN, Barcelona, Spain)
C. Brumlik (Nanobiz LLC, Whitehouse Station, NJ, USA)
T. Burnouf (Human Plasma Product Services, Lille, France)
E. Carrilho (University of São Paulo, São Carlo, SP, Brazil)
V-M. Castaño-Meneses (Universidad Nacional Autónoma de México, México)
A. Cavalcanti (CAN, Melbourne, Australia)
H.T. Chang (National Taiwan University, Taipei, Taiwan)
W.B. Choi (Florida International University, Miami, FL, USA)
B. Chu (State University of New York, Stony Brook, NY, USA)
L. Chung-Kung (Vanung University, Chung-Li, Taiwan)
Z. Dehouche (Université Laval, Québec, Canada)
B. Ding (University of California, Davis, CA, USA)
F. Ding (Rice University, Houston, TX, USA)
Y. Ding (University of Leeds, Leeds, UK)
T. Djenizian (Laboratoire MADIREL, Cedex, France)
A.B. Djurisic (University of Hong Kong, Hong Kong)
A.A. El-Azab (Florida State University, Tallahassee, FL, USA)
D.F. Emerich (LCT BioPharma Inc., Providence, RI, USA)
C. Fernández (Instituto de Microelectrónica de Barcelona, Barcelona, Spain)
A. Freundlich (University of Houston, Houston, TX, USA)
S. Fukuzumi (Osaka University, Osaka, Japan)
M. Goldschmidt (UTHSC-H-Medical School, Houston, TX, USA)
E.M. Gomez ( Research Center on Nanoscience and Nanotechnology, Barcelona, Spain )
P.I. Gouma (State University of New York, Stony Brook, NY, USA)
G. Gruner (University of California, Los Angeles, CA, USA)
D.T. Hayni (Central Michigan University, Mt Pleasant, MI, USA)
M. Henini (University of Nottingham, Nottingham, UK)
M.C. Hersam (Northwestern University, Evanston, IL, USA)
A. Holder (The University of Southern Mississippi, Hattiesburg, MS, USA)
C.-W. Hong (National Tsing Hua University, Hsinchu, Taiwan)
M.Z. Hu (Oak Ridge National Laboratory, Oak Ridge, TN, USA)
C.W. Huck (University of Innsbruck, Innsbruck, Austria)
G.W. Jang (Material and Chemical Research Laboratories, ITRI, Taiwan)
G.B. Jiang (RCEES, Beijing, China)
Q. Jiang (Jilin University, Changchun, China)
D. Jiyan (The Hong Kong Polytechnic University, Hong Kong)
N.V. Kamanina (Vavilov State Optical Institute, St.- Petersburg, Russia)
K.K. Kar (Indian Institute of Technology Kanpur, India)
I. Karafyllidi (Democritus University of Thrace, Xanthi, Greece)
N. Karkare (York Hospital, Pennsylvania, USA)
V. Kasicka (Czech Academy of Science, Prague, Czech Republic)
B.I. Kharisov (Ciudad Universitaria UANL, Nuevo Leon, Mexico)
M.J. Kim (Drexel University, Philadelphia, USA)
N.A. Kotov (University of Michigan, Ann Arbor, MI, USA)
B-K. Ku (National Institute for Occupational Safety and Health, Cincinnati, OH, USA)
M.J. Kumar (Indian Institute of Technology, New Delhi, India)
T.H. Labean (Duke University, Durham, NC, USA)
S.P. Lau (Nanyang Technological University, Singapore)
B.E. Layton (Drexel University, Philadelphia, PA, USA)
G. Li (Chinese Academy of Science, Hefei, China)
C.M. Lieber (Harvard University, Cambridge, MA, USA)
J. Limtrakul (Kasetsart University, Bangkok, Thailand)
B.C. Lin (Chinese Academy of Science, Dalian, China)
J.M. Lin (Chinese Academy of Sciences, Beijing, China)
Y. Lin (Pacific Northwest National Laboratory, Richland, WA, USA)
B. Liu (Tianjin University, Tianjin, China)
C.P. Liu (National Cheng Kung University, Tainan, Taiwan)
I. Lo (National Sun Yat-Sen University, Kaohsiung, Taiwan)
E. Mcglynn (Dublin City University, Dublin, Ireland)
L. Merhari (CERAMEC, Limoges, France)
C. Montemagno (University of Cincinnati, Cincinnati, OH, USA)
S.Y. Myong (Tokyo Institute of Technology, Meguro-ku, Japan)
S. Nazarpour (University of Barcelona, Barcelona, Spain)
O.N. Oliveira (University of São Paulo, São Carlos, Brazil)
A. Pal (Indian Institute of Technology, Kharagpur, India)
D.A. Pawlicka (IQSC-USP, Sao Carlos, Brazil)
G.F. Peng (Beijing JiaoTong University, Beijing, China)
C.C. Perry (Nottingham Trent University, Nottingham, UK)
S.N. Piramanayagam (Data Storage Institute, Singapore)
T. Qiu (Southeast University, Nanjing, China)
M.A. Raggi (University of Bologna, Bologna, Italy)
A. Ramanavicius (Vilnius University, Vilnius, Lithuania)
W.M. Razeghi (Northwestern University, Evanston, IL, USA)
Z. Ren (Boston College,Chestnut Hill, MA, USA)
A.P.-G. Robinson (University of Birmingham, Edgbaston, Birmingham, UK)
G. Rytwo (Tel Hai Academic College, Israel)
P. Serena (Materials Science Institute of Madrid, CSIC, Madrid, Spain)
W.Z. Shen (Shanghai Jiao Tong University, Shanghai, China)
A. Simonian (Auburn University, Auburn, AL, USA)
S.B. Sinnott (University of Florida, Gainesville, FL, USA)
S.K. Srivastava (Indian Institute of Technology, Kharagpur, India)
X.W. Sun (Nanyang University of Technology, Nanyang Avenue, Singapore)
W. Tan (University of Florida, Gainesville, USA)
R. Tenne (Center for Nanoscale Science, Rehovot, Israel)
A. Vazquez (INTEMA-Universidad Nacional de Mar del Plata, Argentina)
D. Wang (Max Planck Institute of Colloids and Interfaces, Potsdam, Germany)
Z.L. Wang (Georgia Institute of Technology Atlanta, Atlanta, GA, USA)
T.J. Webster (Brown University, Providence, RI, USA)
M. Wei (Griffith University, Gold Coast, Australia)
A.D. Wissner-Gross (Harvard University, Cambridge, MA, USA)
R. Wu (University of Florida, Gainesville, FL, USA)
H. Xu (Lund University, Lund, Sweden)
K. Yamamoto (Research Institute of International Medical Center, Tokyo, Japan)
A. Yu (University of New South Wales, Sydney, Australia)
S.F. Yu (Nanyang Technological University, Singapore)
A. Zemva (University of Ljubljana, Ljubljana, Slovenia)
L. Zhang (University of Sydney, Sydney, Australia)
Y. Zhang (National University of Singapore, Singapore)
Y.J. Zhu (Chinese Academy of Sciences, Shanghai, China)
|
